Cargando…
Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth
To identify novel signaling pathways necessary for rhabdomyosarcoma (RMS) survival, we performed a loss-of-function screen using an inducible small hairpin RNA (shRNA) library in an alveolar and an embryonal RMS cell line. This screen identified CRKL expression as necessary for growth of alveolar RM...
Autores principales: | Yeung, C L, Ngo, V N, Grohar, P J, Arnaldez, F I, Asante, A, Wan, X, Khan, J, Hewitt, S M, Khanna, C, Staudt, L M, Helman, L J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898328/ https://www.ncbi.nlm.nih.gov/pubmed/23318429 http://dx.doi.org/10.1038/onc.2012.590 |
Ejemplares similares
-
IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma()
por: Wan, Xiaolin, et al.
Publicado: (2015) -
CRKL is a critical target of Hh‐GLI2 pathway in lung adenocarcinoma
por: Liu, Xiaoming, et al.
Publicado: (2021) -
The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma()
por: Heske, Christine M., et al.
Publicado: (2016) -
Capability of the viral NS1 proteins to bind to the cellular adaptor proteins Crk and CrkL determines sensitivity of influenza viruses to Crk/CrkL expression
por: Hrincius, ER, et al.
Publicado: (2009) -
Crk and CrkL as Therapeutic Targets for Cancer Treatment
por: Park, Taeju
Publicado: (2021)